CB
SER icon

Community Bank’s Serina Therapeutics SER Stock Holding History

Community Bank’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 482
2021
Q3 		$0 Buy
+1
New +$42 ﹤0.01% 505

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Community Bank's SER Position: Q4 2021 in Review

Community Bank sold out of Serina Therapeutics (SER) in Q4 2021, closing a stake of 1 share.

Community Bank first reported a position in SER in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 35 funds tracked by Wall St. Rank hold SER as of Q4 2021.

  • Community Bank reported no remaining Serina Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Community Bank sold 1 Serina Therapeutics share in Q4 2021.
  • Community Bank first reported a position in Serina Therapeutics in Q3 2021 and held it in 1 quarter.
  • Community Bank's Serina Therapeutics position peaked at $0 in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Serina Therapeutics as of Q4 2021.

Based on Community Bank's 13F filing for Q4 2021, filed 27 Jan 2022.